103 related articles for article (PubMed ID: 3291938)
1. The effect of epostane, a 3-beta hydroxy steroid dehydrogenase inhibitor, on maternal and fetal steroid levels during mid-gestation.
Selinger M; MacKenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1988 Jun; 95(6):596-601. PubMed ID: 3291938
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 3 beta-hydroxysteroid dehydrogenase in the sow near term: effects on fetal and maternal steroids and on delivery.
Silver M; Fowden AL
Q J Exp Physiol; 1988 Jan; 73(1):67-78. PubMed ID: 3162325
[TBL] [Abstract][Full Text] [Related]
3. Effects on maternal and fetal steroid concentrations of induction of parturition in the sheep by inhibition of 3 beta-hydroxysteroid dehydrogenase.
Silver M
J Reprod Fertil; 1988 Mar; 82(2):457-65. PubMed ID: 2834551
[TBL] [Abstract][Full Text] [Related]
4. The placental transfer of mifepristone (RU 486) during the second trimester and its influence upon maternal and fetal steroid concentrations.
Hill NC; Selinger M; Ferguson J; MacKenzie IZ
Br J Obstet Gynaecol; 1990 May; 97(5):406-11. PubMed ID: 2372525
[TBL] [Abstract][Full Text] [Related]
5. Induction of labour in sheep by inhibition of 3-beta hydroxysteroid dehydrogenase: role of the fetal adrenal.
Silver M; Fowden AL
J Dev Physiol; 1991 Mar; 15(3):169-74. PubMed ID: 1658115
[TBL] [Abstract][Full Text] [Related]
6. Effect of an inhibitor of 3 beta-hydroxysteroid dehydrogenase on progesterone concentrations and embryo survival in sheep.
Ashworth CJ; Wilmut I; Springbett AJ; Webb R
J Endocrinol; 1987 Feb; 112(2):205-13. PubMed ID: 3469294
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibiting 3 beta-hydroxysteroid dehydrogenase on plasma progesterone and other steroids in the pregnant mare near term.
Fowden AL; Silver M
J Reprod Fertil Suppl; 1987; 35():539-45. PubMed ID: 3479607
[TBL] [Abstract][Full Text] [Related]
8. Myometrial activity in first trimester human pregnancy after Epostane therapy. Effect of intravenous oxytocin.
Webster MA; Pattison NS; Phipps SL; Gillmer MD
Br J Obstet Gynaecol; 1985 Sep; 92(9):957-62. PubMed ID: 3862426
[TBL] [Abstract][Full Text] [Related]
9. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries.
Webster MA; Phipps SL; Gillmer MD
Br J Obstet Gynaecol; 1985 Sep; 92(9):963-8. PubMed ID: 3862427
[TBL] [Abstract][Full Text] [Related]
10. Induction of parturition in swine and epostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase.
Martin PA; Hammitt DG; Strohbehn RS; Keister DM
J Anim Sci; 1987 Feb; 64(2):497-506. PubMed ID: 3470276
[TBL] [Abstract][Full Text] [Related]
11. Termination of early pregnancy by the 3 beta-hydroxysteroid dehydrogenase inhibitor epostane.
Crooij MJ; de Nooyer CC; Rao BR; Berends GT; Gooren LJ; Janssens J
N Engl J Med; 1988 Sep; 319(13):813-7. PubMed ID: 3166108
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of preovulatory gonadotrophin surges by epostane: a new inhibitor of 3 beta-hydroxysteroid dehydrogenase.
DePaolo LV
J Endocrinol; 1988 Jul; 118(1):59-68. PubMed ID: 3137304
[TBL] [Abstract][Full Text] [Related]
13. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
[TBL] [Abstract][Full Text] [Related]
14. Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys.
Haluska GJ; Cook MJ; Novy MJ
Am J Obstet Gynecol; 1997 Mar; 176(3):682-91. PubMed ID: 9077629
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of progesterone and oestradiol-17 beta after administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to sheep in late pregnancy.
Taylor MJ
J Endocrinol; 1987 Apr; 113(1):97-101. PubMed ID: 3473174
[TBL] [Abstract][Full Text] [Related]
16. Effects of epostane on ovarian levels of progesterone, 17 beta-estradiol, prostaglandin E2, and prostaglandin F2 alpha during ovulation in the gonadotropin-primed immature rat.
Espey LL; Adams RF; Tanaka N; Okamura H
Endocrinology; 1990 Jul; 127(1):259-63. PubMed ID: 2361472
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in first- and second-trimester human pregnancy and the luteal phase using Epostane.
Pattison NS; Webster MA; Phipps SL; Anderson AB; Gillmer MD
Fertil Steril; 1984 Dec; 42(6):875-81. PubMed ID: 6437877
[TBL] [Abstract][Full Text] [Related]
18. Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy.
Hill NC; Selinger M; Ferguson J; MacKenzie IZ
Hum Reprod; 1991 Mar; 6(3):458-62. PubMed ID: 1955558
[TBL] [Abstract][Full Text] [Related]
19. Is maternal progesterone actually independent of the fetal steroids?
Hill M; Pařízek A; Jirásek JE; Jirkovská M; Velíková M; Dušková M; Klímková M; Pasková A; Zizka Z; Germanová A; Koucký M; Kalousová M; Stárka L
Physiol Res; 2010; 59(2):211-224. PubMed ID: 19537920
[TBL] [Abstract][Full Text] [Related]
20. Induction of abortion in early first trimester human pregnancy using epostane.
Webster MA; Gillmer MD
Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
